Clinical trial
Association Between Rosiglitazone Use and Clinical Course of Diabetic…
NCT00497666 · Assaf-Harofeh Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00497666 |
|---|---|
| Title | Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study |
| Official title | Retrospective Study Evaluating the Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study |
| Lead sponsor | Assaf-Harofeh Medical Center, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Diabetes, Diabetic Nephropathy, Renal Protection |
| Intervention type | Drug |
| Interventions | Rosiglitasone (retrospective observation) |
| Start date | Aug 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jul 9, 2007 |
| Last update posted | Jul 9, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: